AP NEWS

Global Neurostimulation Devices Market 2018-2022|11% CAGR Projection Over the Next Four Years | Technavio

December 27, 2018

LONDON--(BUSINESS WIRE)--Dec 27, 2018-- analysts forecast the global neurostimulation devices market to grow at a CAGR of nearly 11% during the forecast period, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181227005182/en/

Technavio has published a new market research report on the global neurostimulation devices market from 2018-2022. (Graphic: Business Wire)

Expanding indications of neurostimulation devices is one of the major trends being witnessed in the . Several neurostimulation devices have recently received approvals for indications and are ongoing clinical trials to explore their additional therapeutic properties. Earlier, neuropathic pain conditions have been difficult to treat as the pain stems from tissue and nerve damage, the disruption of the peripheral nervous system or CNS, or the transmission of pain signals. Available chronic pain therapies such as medication, opioids, and surgery have been unsuccessful in the alleviation of pain in patients with such conditions.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global neurostimulation devices market is the rising prevalence of neurological disorders:

Global neurostimulation devices market: Rising prevalence of neurological disorders

Globally, the prevalence of several neurological disorders is increasing. In 2015, neurological disorders caused 250,692 million disability-adjusted life years (DALY), comprising 10.2% of the global DALY, and 9.399 million deaths, comprising 16.8% of all deaths. In 2017, nearly one in every five people across the world suffered from chronic pain. One of the most prevalent and undertreated forms of chronic pain is neuropathic pain. In 2017, in the US and Europe, nearly 1.4% of the population had some degree of neuropathic pain. In the same year, approximately 1,300 out of every 1 million people across the world had PD.

According to a senior analyst at Technavio for research on health care equipment, “The probability of diseases such as AD, PD, UI, fecal incontinence, epilepsy, dementia, and movement disorders increases significantly with age. Hence, the prevalence of neurological disorders increases owing to the growth of the aging population. Other risk factors related with neurological disorders such as high blood pressure, obesity, and the consumption of alcohol and tobacco are also increasing. Therefore, the rising prevalence of neurological disorders will drive the growth of the global neurostimulation devices market.”

Global neurostimulation devices market: Segmentation analysis

The global neurostimulation devices market research report provides market segmentation by product (implantable neurostimulation devices and external neurostimulation devices) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The implantable neurostimulation devices segment held the largest market share in 2017, accounting for over 84% of the market. This product segment is expected to dominate the global market throughout the forecast period.

The Americas led the market in 2017 with a market share of nearly 63%. This region is expected to dominate the market through 2022, however there will be a decrease in its market share by over 8%.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20181227005182/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL GENERAL HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 12/27/2018 09:40 AM/DISC: 12/27/2018 09:40 AM

http://www.businesswire.com/news/home/20181227005182/en

AP RADIO
Update hourly